Exploring the policies applied to pharmaceutical care practice for type 2 diabetes over the last decade in european community pharmacies

Detalhes bibliográficos
Autor(a) principal: Pizarro,Ângela Maria Vilaça Pereira de Araújo
Data de Publicação: 2021
Outros Autores: Martins,Maria Rosário O., Simões,Jorge Almeida
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://scielo.pt/scielo.php?script=sci_arttext&pid=S2504-31452021000200103
Resumo: Abstract In the last decade (2010-2020), more than half of European countries have improved their health policies within the primary care for type 2 diabetes mellitus. Community pharmacies have been and could continue to be essential actors in this evolution of fighting the disease by providing a set of pharmacotherapeutic follow-up services for the person with diabetes. These services, designated by the Pharmaceutical Group of the European Union as “diabetes management” and “glucose measurement”, have aimed to optimize adherence to therapy and improve health outcomes. However, to follow the European guidelines of Good Pharmacy Practice, providing these services implies having a normative framework or a legal basis. Thus, this study sought to analyze the normative and regulatory framework on which community pharmacies in 28 European countries were based on providing this health care over the last decade.
id RCAP_8491d279c9130bc8d54e44b3b3c5d96e
oai_identifier_str oai:scielo:S2504-31452021000200103
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Exploring the policies applied to pharmaceutical care practice for type 2 diabetes over the last decade in european community pharmaciesType 2 diabetes mellitusCommunity pharmacy servicesHealth policiesRegulatory policiesAbstract In the last decade (2010-2020), more than half of European countries have improved their health policies within the primary care for type 2 diabetes mellitus. Community pharmacies have been and could continue to be essential actors in this evolution of fighting the disease by providing a set of pharmacotherapeutic follow-up services for the person with diabetes. These services, designated by the Pharmaceutical Group of the European Union as “diabetes management” and “glucose measurement”, have aimed to optimize adherence to therapy and improve health outcomes. However, to follow the European guidelines of Good Pharmacy Practice, providing these services implies having a normative framework or a legal basis. Thus, this study sought to analyze the normative and regulatory framework on which community pharmacies in 28 European countries were based on providing this health care over the last decade.Escola Nacional de Saúde Pública2021-09-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articletext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S2504-31452021000200103Portuguese Journal of Public Health v.39 n.2 2021reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttp://scielo.pt/scielo.php?script=sci_arttext&pid=S2504-31452021000200103Pizarro,Ângela Maria Vilaça Pereira de AraújoMartins,Maria Rosário O.Simões,Jorge Almeidainfo:eu-repo/semantics/openAccess2024-02-06T17:34:33Zoai:scielo:S2504-31452021000200103Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T02:36:28.959251Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Exploring the policies applied to pharmaceutical care practice for type 2 diabetes over the last decade in european community pharmacies
title Exploring the policies applied to pharmaceutical care practice for type 2 diabetes over the last decade in european community pharmacies
spellingShingle Exploring the policies applied to pharmaceutical care practice for type 2 diabetes over the last decade in european community pharmacies
Pizarro,Ângela Maria Vilaça Pereira de Araújo
Type 2 diabetes mellitus
Community pharmacy services
Health policies
Regulatory policies
title_short Exploring the policies applied to pharmaceutical care practice for type 2 diabetes over the last decade in european community pharmacies
title_full Exploring the policies applied to pharmaceutical care practice for type 2 diabetes over the last decade in european community pharmacies
title_fullStr Exploring the policies applied to pharmaceutical care practice for type 2 diabetes over the last decade in european community pharmacies
title_full_unstemmed Exploring the policies applied to pharmaceutical care practice for type 2 diabetes over the last decade in european community pharmacies
title_sort Exploring the policies applied to pharmaceutical care practice for type 2 diabetes over the last decade in european community pharmacies
author Pizarro,Ângela Maria Vilaça Pereira de Araújo
author_facet Pizarro,Ângela Maria Vilaça Pereira de Araújo
Martins,Maria Rosário O.
Simões,Jorge Almeida
author_role author
author2 Martins,Maria Rosário O.
Simões,Jorge Almeida
author2_role author
author
dc.contributor.author.fl_str_mv Pizarro,Ângela Maria Vilaça Pereira de Araújo
Martins,Maria Rosário O.
Simões,Jorge Almeida
dc.subject.por.fl_str_mv Type 2 diabetes mellitus
Community pharmacy services
Health policies
Regulatory policies
topic Type 2 diabetes mellitus
Community pharmacy services
Health policies
Regulatory policies
description Abstract In the last decade (2010-2020), more than half of European countries have improved their health policies within the primary care for type 2 diabetes mellitus. Community pharmacies have been and could continue to be essential actors in this evolution of fighting the disease by providing a set of pharmacotherapeutic follow-up services for the person with diabetes. These services, designated by the Pharmaceutical Group of the European Union as “diabetes management” and “glucose measurement”, have aimed to optimize adherence to therapy and improve health outcomes. However, to follow the European guidelines of Good Pharmacy Practice, providing these services implies having a normative framework or a legal basis. Thus, this study sought to analyze the normative and regulatory framework on which community pharmacies in 28 European countries were based on providing this health care over the last decade.
publishDate 2021
dc.date.none.fl_str_mv 2021-09-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S2504-31452021000200103
url http://scielo.pt/scielo.php?script=sci_arttext&pid=S2504-31452021000200103
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S2504-31452021000200103
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Escola Nacional de Saúde Pública
publisher.none.fl_str_mv Escola Nacional de Saúde Pública
dc.source.none.fl_str_mv Portuguese Journal of Public Health v.39 n.2 2021
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137416128233472

Registros relacionados